Filed with the SEC as KUMAR AMIT; the order above is the one the filer's own signature uses.
In the 12 months to Nov 8, 2026, on the open market: bought $221K of ANIX. Filed a median of 1 business day after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
Insider purchases above the line: $221KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
ANIXBought: Anixa Biosciences Inc Oct 30, 20265,000 sharesfiled Nov 2, 2026685,000 shares held directly after, as filedfiling$16K
ANIXBought: Anixa Biosciences Inc Oct 22, 20268,000 sharesfiled Oct 22, 2026680,000 shares held directly after, as filedfiling$22K
ANIXBought: Anixa Biosciences Inc Sep 24, 20267,000 sharesfiled Sep 28, 2026672,000 shares held directly after, as filedfiling$19K
ANIXBought: Anixa Biosciences Inc Jul 24, 20263,000 sharesfiled Jul 27, 2026643,812 shares held directly after, as filedfiling$11K
ANIXBought: Anixa Biosciences Inc Jul 20, 20265,000 sharesfiled Jul 21, 2026640,812 shares held directly after, as filedfiling$17K
ANIXBought: Anixa Biosciences Inc Jul 10, 20265,000 sharesfiled Jul 13, 2026635,812 shares held directly after, as filedfiling$15K
ANIXBought: Anixa Biosciences Inc Jun 12, 202621,000 sharesfiled Jun 16, 2026630,812 shares held directly after, as filedfiling$52K
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.
